Enhancement of slow wave sleep: Implications for insomnia

Journal of Clinical Sleep Medicine

Volumn 5, Issue 2 SUPPL., 2009, Pages

  Walsh, James K ^a,b  

^a SAINT LOUIS UNIVERSITY   (United States)

^b Sleep Medicine and Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; EPLIVANSERIN; GABAPENTIN; GABOXADOL; MIRTAZAPINE; OLANZAPINE; PLACEBO; PREGABALIN; RITANSERIN; TIAGABINE; TRAZODONE; ZOLPIDEM;

ARTICLE; CLINICAL TRIAL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG RESPONSE; ELECTROENCEPHALOGRAPHY; HEMOSTASIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INSOMNIA; MENTAL DISEASE; NIGHT SLEEP; NONREM SLEEP; POLYSOMNOGRAPHY; REM SLEEP; SEDATION; SIDE EFFECT; SLEEP DISORDER; SLEEP INDUCTION; SLEEP PATTERN; SLEEP TIME; SLOW WAVE SLEEP; WAKEFULNESS;

EID: 65349165284     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.5.2s.s27     Document Type: Article

References (43)

1. Horne J. Human slow wave sleep: a review and appraisal of recent findings, with implications for sleep functions, and psychiatric illness. Experientia 1992;48:941-54.
2. Benington JH, Heller HC. Restoration of brain energy metabolism as the function of sleep. Prog Neurobiol 1995;45:347-60.
3. Dijk DJ, Brunner DP, Beersma DG, Borbely AA. Electroencephalogram power density and slow wave sleep as a function of prior waking and circadian phase. Sleep 1990;13:430-40.
4. Werth E, Dijk DJ, Achermann P, Borbely AA. Dynamics of the sleep EEG after an early evening nap: experimental data and simulations. Am J Physiol 1996;271:R501-R510.
5. Borbely AA, Baumann F, Brandeis D, Strauch I, Lehmann D. Sleep deprivation: effect on sleep stages and EEG power density in man. Electroencephalogr Clin Neurophysiol 1981;51:483-95.
6. Bonnet MH. Sleep restoration as a function of periodic awakening, movement, or electroencephalographic change. Sleep 1987;10:364-73.
7. Borbely AA. A two process model of sleep regulation. Hum Neurobiol 1982;1:195-204.
8. Tononi G, Cirelli C. Sleep and synaptic homeostasis: a hypothesis. Brain Res Bull 2003;62:143-50.
9. Fink-Jensen A, Suzdak PD, Swedberg MD, et al. The gamma-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats. Eur J Pharmacol 1992;220:197-201.
10. Winsky-Sommerer R, Vyazovskiy VV, Homanics GE, Tobler I. The EEG effects of THIP (Gaboxadol) on sleep and waking are mediated by the GABA(A)delta-subunit-containing receptors. Eur J Neurosci 2007;25:1893-9.
11. Chandra D, Jia F, Liang J, et al. GABAA receptor alpha 4 subunits mediate extrasynaptic inhibition in thalamus and dentate gyrus and the action of gaboxadol. Proc Nad Acad Sci U S A 2006;103:15230-5.
12. Walsh JK, Randazzo AC, Stone K, et al. Tiagabine is associated with sustained attention during sleep restriction: evidence for the value of slow-wave sleep enhancement? Sleep 2006;29:433-43.
13. Walsh JK, Snyder E, Hall J, et al. Slow wave sleep enhancement with gaboxadol reduces daytime sleepiness during sleep restriction. Sleep 2008;31:659-72.
14. Van Dongen HP, Maislin G, Mullington JM, Dinges DF. The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep 2003;26:117-26.
15. Merica H, Blois R, Gaillard JM. Spectral characteristics of sleep EEG in chronic insomnia. Eur J Neurosci 1998;10:1826-34.
16. Walsh JK, Zammit G, Schweitzer PK, Ondrasik J, Roth T. Tiagabine enhances slow wave sleep and sleep maintenance in primary insomnia. Sleep Med 2006;7:155-61.
17. Walsh JK, Perlis M, Rosenthal M, et al. Tiagabine increases slow-wave sleep in a dose-dependent fashion without affecting traditional efficacy measures in adults with primary insomnia. J Clin Sleep Med 2006;2:35-41.
18. Roth T, Wright KP, Jr., Walsh J. Effect of tiagabine on sleep in elderly subjects with primary insomnia: a randomized, double-blind, placebo-controlled study. Sleep 2006;29:335-41.
19. Walsh JK, Deacon S, Dijk DJ, Lundahl J. The selective extrasynaptic GABAA agonist, gaboxadol, improves traditional hypnotic efficacy measures and enhances slow wave activity in a model of transient insomnia. Sleep 2007;30:593-602.
20. Lundahl J, Staner L, Staner C, Loft H, Deacon S. Short-term treatment with gaboxadol improves sleep maintenance and enhances slow wave sleep in adult patients with primary insomnia. Psychopharmacology (Berl) 2007;195:139-46.
21. Deacon S, Staner L, Staner C, et al. Effect of short-term treatment with gaboxadol on sleep maintenance and initiation in patients with primary insomnia. Sleep 2007;30:281-7.
22. Hindmarch I, Saubadu S, Delfolie A, Martinez JM, Pinquier JL. Sleep and psychomotor performance in healthy subjects after morning or evening administration of eplivanserin, a novel sleep compound. J Sleep Res 2008;17 (Suppl.1). Abstract No. P359.
23. Estivill E, Renault-Djouadi J, Hecquet C. Eplivanserin, a novel sleep compound, reduces night-time awakenings in patients with sleep maintenance insomnia without evidence of residual effects. J Sleep Res 2008;17 (Suppl. 1). Abstract No. O60.
24. Bonnet MH, Arand DL. Insomnia, metabolic rate and sleep restoration. J Intern Med 2003;254:23-31.
25. Bonnet MH, Arand DL. Heart rate variability in insomniacs and matched normal sleepers. Psychosom Med 1998;60:610-5.
26. Rodenbeck A, Huether G, Ruther E, Hajak G. Interactions between evening and nocturnal cortisol secretion and sleep parameters in patients with severe chronic primary insomnia. Neurosci Lett 2002;324:159-63.
27. Nofzinger EA, Nissen C, Germain A, et al. Regional cerebral metabolic correlates of WASO during NREM sleep in insomnia. J Clin Sleep Med 2006;2:316-22.
28. Stepanski E, Zorick F, Roehrs T, Roth T. Effects of sleep deprivation on daytime sleepiness in primary insomnia. Sleep 2000;23:215-9.
29. Vgontzas AN, Tsigos C, Bixler EO, et al. Chronic insomnia and activity of the stress system: a preliminary study. J Psychosom Res 1998;45:21-31.
30. Backhaus J, Junghanns K, Bom J, et al. Impaired declarative memory consolidation during sleep in patients with primary insomnia: Influence of sleep architecture and nocturnal cortisol release. Biol Psychiatry 2006;60:1324-30.
31. Walker M. The role of slow wave sleep in memory processing. J Clin Sleep Med, Supplement 2009;5:S20-26.
32. Buzsáki G. Memory consolidation during sleep: a neurophysiological perspective. J Sleep Res 1998;7 Suppl 1:17-23.
33. Rasch B, Buchel C, Gais S, Born J. Odor cues during slow-wave sleep prompt declarative memory consolidation. Science 2007;315:1426-9.
34. Yoo SS, Hu PT, Gujar N, Jolesz FA, Walker MP. A deficit in the ability to form new human memories without sleep. Nat Neurosci 2007;10:385-92.
35. Marshall L, Helgadottir H, Molle M, Born J. Boosting slow oscillations during sleep potentiates memory. Nature 2006;444:610-3.
36. Mathias S, Wetter TC, Steiger A, Lancet M. The GABA uptake inhibitor tiagabine promotes slow wave sleep in normal elderly subjects. Neurobiol Aging 2001;22:247-53.
37. Bazil CW, Battista J, Basner RC. Gabapentin improves sleep in the presence of alcohol. J Clin Sleep Med 2005;1:284-7.
38. Hindmarch I, Dawson J, Stanley N. A double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placebo. Sleep 2005;28:187-93.
39. Pardi D, Black J. gamma-Hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness. CNS Drugs 2006;20:993-1018.
40. Dahlitz M, Wells P, James R, Idzikowski C, Parkes JD. Treatment of insomnia with ritanserin. Lancet 1990;336:379.
41. Shen J, Chung SA, Kayumov L, et al. Polysomnographic and symptomatological analyses of major depressive disorder patients treated with mirtazapine. Can J Psychiatry 2006;51:27-34.
42. Sharpley AL, Attenburrow ME, Hafizi S, Cowen PJ. Olanzapine increases slow wave steep and steep continuity in SSRI-resistant depressed patients. J Clin Psychiatry 2005;66:450-4.
43. Mendelson WB. A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry 2005;66:469-76.